Mark James Litton Sells 25,107 Shares of Athira Pharma, Inc. (NASDAQ:ATHA) Stock
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 25,107 shares of Athira Pharma stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $0.56, for a total value of $14,059.92. Following the sale, the chief executive officer now directly owns 242,591 shares of […]
More Stories
Contrasting Veritex (NASDAQ:VBTX) & Texas Capital Bancshares (NASDAQ:TCBI)
Texas Capital Bancshares (NASDAQ:TCBI – Get Free Report) and Veritex (NASDAQ:VBTX – Get Free Report) are both finance companies, but...
Biden Signs Law to Increase Social Security Benefits for Millions
By Joseph Lord President Joe Biden on Jan. 5 signed into law a bill that would increase Social Security benefits...
New York City’s Congestion Pricing Plan Starts on Jan. 5: Everything You Need to Know
By Michael Washburn On Jan. 5, 2025, the long-debated and fiercely contested policy of congestion pricing comes into effect in...
Why ‘Holding It In’ Could Damage Your Bladder, Doctors Warn
By George Citroner When the bladder needs relief, many often ignore their body’s cues for the sake of productivity or...
New Orleans Mourns Victims of Truck Attack With Tearful Vigil and Celebration of Life
By The Associated Press NEW ORLEANS—New Orleans mourned, wept, and danced at a vigil Saturday evening along the famous thoroughfare...
Ajinomoto (OTCMKTS:AJINY) Shares Cross Below 50 Day Moving Average – Should You Sell?
Ajinomoto Co., Inc. (OTCMKTS:AJINY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Friday...